{"id":6018,"date":"2014-06-19T12:05:00","date_gmt":"2014-06-19T12:05:00","guid":{"rendered":"http:\/\/www.pharma-mkting.com\/fda-has-one-more-internet-guidance-to\/"},"modified":"2019-02-21T01:16:33","modified_gmt":"2019-02-21T01:16:33","slug":"fda-has-one-more-internet-guidance-to","status":"publish","type":"post","link":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/fda-has-one-more-internet-guidance-to\/","title":{"rendered":"FDA Has One More Internet Guidance to Publish in 2014: Links"},"content":{"rendered":"
\n<\/a><\/div>\n

In January, 2014, FDA published its “Guidance Agenda: New & Revised Draft Guidances CDER is Planning to Publish During Calendar Year 2014,” which included these promised social media\/Internet guidances under the “Advertising” category:<\/p>\n

    \n
  1. Internet\/Social Media Platforms with Character Space Limitations<\/b>: Presenting Risk and Benefit Information for Prescription Drugs and Medical Devices<\/li>\n

    <\/p>\n

  2. Internet\/Social Media Platforms: Correcting Independent-Third Party Misinformation<\/b> About Prescription Drugs and Medical Devices<\/li>\n

    <\/p>\n

  3. Internet\/Social Media Advertising and Promotional Labeling of Prescription Drugs and Medical Devices \u2013 Use of Links<\/b><\/li>\n<\/ol>\n

    #1 and #2 were just published (see “FDA to Pharma: Forget About Tweets! But You Can Host Discussion Forums About Branded Rx Products, Sorta, & Kinda Correct Misinformation<\/a>“).<\/p>\n

    Will FDA publish Guidance #3 before the July 9, 2014, deadline imposed by Congress (see here<\/a>)? Or will it miss that deadline? When it does publish this guidance, will it address ALL the issues about links raised by the FDA prior to the November, 2009, public hearing? What’s the opinion of pharma marketers regarding these issues? Read on.<\/p>\n

    <\/a>Links<\/b>
    \nPrior to the November, 2009, public hearing, FDA posted these questions and requests for clarification about links:<\/p>\n